SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:liu-140034"
 

Sökning: id:"swepub:oai:DiVA.org:liu-140034" > Antiarrhythmic medi...

Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation

Alhede, Christina (författare)
Herlev Gentofte University Hospital, Denmark
Lauridsen, Trine K. (författare)
Herlev Gentofte University Hospital, Denmark
Johannessen, Arne (författare)
Herlev Gentofte University Hospital, Denmark
visa fler...
Dixen, Ulrik (författare)
Hvidovre University Hospital, Denmark
Jensen, Jan S. (författare)
Herlev Gentofte University Hospital, Denmark
Raatikainen, Pekka (författare)
Helsinki University Hospital, Finland
Hindricks, Gerhard (författare)
Leipzig University Hospital, Germany
Walfridsson, Håkan (författare)
Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US
Kongstad, Ole (författare)
Lund University Hospital, Sweden
Pehrson, Steen (författare)
Rigshosp, Denmark
Englund, Anders (författare)
Örebro University Hospital, Sweden
Hartikainen, Juha (författare)
Kupio University Hospital, Finland
Hansen, Peter S. (författare)
Varde Heart Centre, Denmark
Nielsen, Jens C. (författare)
Aarhus University Hospital, Denmark
Jons, Christian (författare)
Rigshosp, Denmark
visa färre...
 (creator_code:org_t)
ELSEVIER IRELAND LTD, 2017
2017
Engelska.
Ingår i: International Journal of Cardiology. - : ELSEVIER IRELAND LTD. - 0167-5273 .- 1874-1754. ; 244, s. 186-191
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Supraventricular ectopic complexes (SVEC) originating in the pulmonary veins are known triggers of atrial fibrillation (AF) which led to the development of pulmonary vein isolation for AF. However, the long-term prevalence of SVEC after catheter ablation (CA) as compared to antiarrhythmic medication (AAD) is unknown. Our aims were to compare the prevalence of SVEC after AAD and CA and to estimate the association between baseline SVEC burden and AF burden during 24 months of follow-up. Methods: Patients with paroxysmal AF (N = 260) enrolled in the MANTRA PAF trial were treated with AAD (N = 132) or CA (N = 128). At baseline and 3, 6, 12, 18 and 24 months follow-up patients underwent 7-day Holter monitoring to assess SVEC and AF burden. We compared SVEC burden between treatments with Wilcoxon sum rank test. Results: Patients treated with AAD had significantly lower daily SVEC burden during follow-up as compared to CA (AAD: 19 [6-58] versus CA: 39 [14-125], p = 0.003). SVEC burden increased post-procedurally followed by a decrease after CA whereas after AAD SVEC burden decreased and stabilized after 3 months of follow-up. Patients with low SVEC burden had low AF burden after both treatments albeit this was more pronounced after CA at 24 months of follow-up. Conclusion: AAD was superior to CA in suppressing SVEC burden after treatment of paroxysmal AF. After CA SVEC burden increased immediately post-procedural followed by a decrease whereas after AAD an early decrease was observed. Lower SVEC burden was highly associated with lower AF burden during follow-up especially after CA. (C) 2017 Elsevier B.V. All rights reserved.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Arrhythmia; Treatment; Ablation; Premature ectopic beats; Recurrence

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy